About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

HFpEF and 2-year Mortality of COPD Patients | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT04277429

HFpEF and 2-year Mortality of COPD Patients

This study was designed to assess potential relationship between heart failure with preserved ejection fraction and 2- year mortality of patients with chronic obstructive pulmonary disease

Lead sponsor: University Hospital Olomouc•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Milan Sova, Ph.D.

CONTACT

588445326 milan.sova@email.cz

Ondrej Zela, MD

CONTACT

ondrej.zela@gmail.com

Sponsors

Lead Sponsor

University Hospital Olomouc

Age

40 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Exacerbation of chronic obstructive pulmonary disease requiring hospitalization
•Age 40 - 80 years
•Performance status 0-1 according to Eastern Cooperative Oncology Group (ECOG)
•Long acting beta agonist (LABA)/ long acting antimuscarinic (LAMA) bronchodilator treatment

Exclusion Criteria

•Presence of major heart valve dysfunction
•Documented noncompliance with treatment
•Presence of active malignancy
•Body mass index \> 40
•Interstitial lung disease

Related studies

Effect of Personalized Follow-up in Adapted Physical Activities in Subjects With Chronic Heart Failure.

NCT06222762 · Heart Failure

Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation

NCT07665931 · Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hyperinflation

Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades

NCT06052475 · Pacing-Induced Cardiomyopathy, Heart Failure

Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany

NCT06675552 · Heart Disease, Heart Failure, and more

RECRUITINGPhase 2

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

NCT07646587 · COPD (Chronic Obstructive Pulmonary Disease)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 2, 2022Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment150

Start dateJul 2020

Last updatedNov 2, 2022

Condition

Chronic Obstructive Pulmonary Disease Heart Failure

Locations shown

Frydek Mistek Hospital

Frýdek-Místek

University Hospital Olomou

Olomouc

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions